Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
Year: 2006
Type: article
Source: Molecular Cancer Therapeutics
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: THE THERAPY OF AML
OpenAlex ID: W2126983941
